全文获取类型
收费全文 | 9758篇 |
免费 | 830篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 90篇 |
儿科学 | 360篇 |
妇产科学 | 343篇 |
基础医学 | 1298篇 |
口腔科学 | 122篇 |
临床医学 | 1043篇 |
内科学 | 1873篇 |
皮肤病学 | 243篇 |
神经病学 | 1000篇 |
特种医学 | 190篇 |
外国民族医学 | 1篇 |
外科学 | 1382篇 |
综合类 | 378篇 |
一般理论 | 9篇 |
预防医学 | 991篇 |
眼科学 | 197篇 |
药学 | 502篇 |
中国医学 | 12篇 |
肿瘤学 | 589篇 |
出版年
2023年 | 70篇 |
2022年 | 112篇 |
2021年 | 257篇 |
2020年 | 149篇 |
2019年 | 284篇 |
2018年 | 332篇 |
2017年 | 219篇 |
2016年 | 256篇 |
2015年 | 271篇 |
2014年 | 327篇 |
2013年 | 413篇 |
2012年 | 670篇 |
2011年 | 717篇 |
2010年 | 395篇 |
2009年 | 340篇 |
2008年 | 551篇 |
2007年 | 599篇 |
2006年 | 552篇 |
2005年 | 503篇 |
2004年 | 379篇 |
2003年 | 359篇 |
2002年 | 337篇 |
2001年 | 230篇 |
2000年 | 244篇 |
1999年 | 211篇 |
1998年 | 87篇 |
1997年 | 74篇 |
1996年 | 71篇 |
1995年 | 61篇 |
1994年 | 55篇 |
1993年 | 44篇 |
1992年 | 135篇 |
1991年 | 124篇 |
1990年 | 115篇 |
1989年 | 105篇 |
1988年 | 126篇 |
1987年 | 97篇 |
1986年 | 101篇 |
1985年 | 67篇 |
1984年 | 64篇 |
1983年 | 45篇 |
1982年 | 37篇 |
1981年 | 37篇 |
1980年 | 33篇 |
1979年 | 37篇 |
1978年 | 26篇 |
1977年 | 29篇 |
1976年 | 34篇 |
1974年 | 45篇 |
1973年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
O’Beirne Sarah L. Chazen J. Levi Cornman-Homonoff Joshua Carey Bridget T. Gelbman Brian D. 《Lung》2019,197(6):727-733
Lung - Diaphragmatic paralysis (DP) is an important cause of dyspnea with many underlying etiologies; however, frequently no cause is identified despite extensive investigation. We hypothesized... 相似文献
4.
5.
A. Armentia S. Martín-Armentia A. Moral D. Montejo B. Martin-Armentia R. Sastre S. Fernández A. Corell D. Fernandez 《Allergologia et immunopathologia》2019,47(4):350-356
Introduction and objectivesBiological aerosols play a vital role in the interactions between the atmosphere, biosphere, climate and public health and fungal spores are a component with allergic importance.We constructed a database in Castile & Leon (Spain) and carry out molecular-level component-resolved diagnosis to complete the air quality study carried out since 2006 by our aerobiological network (RACYL) to aid clinical diagnosis and treatment.MethodsWe reviewed a database of 19,774 patients (adults and children) with allergic respiratory disease treated in our unit during the last 12 years. We also made a component-resolved diagnosis of the molecules involved in the pathology in a randomly selected population of 150 patients.ResultsThe dimeric glycoprotein Alt a1 from Alternaria is the most prevalent and most useful allergen in the diagnosis of patients with allergy to fungi in our area (94.4%), followed by enolase Alt a 6 (Alternaria), ribonuclease Asp f 1 of Aspergillus and mannitol dehydrogenase from Cla h 8 (Cladosporium).ConclusionsOur results have helped determine which spore molecules are most-closely associated with allergies. Molecular analysis will be useful to determine more accurate and useful immunotherapy in these patients. 相似文献
6.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
7.
Oral allergy syndrome induced by spinach 总被引:1,自引:1,他引:0
I. Sanchez F. Rodriguez J. L. Garcia-Abujeta L. Fernandez D. Quiñones D. Martin-Gil 《Allergy》1997,52(12):1245-1246
8.
We report a case of vasoactive-agent-induced priapism successfully treated in the emergency department with 10 mg of metaraminol injected into the corpora cavernosa. 相似文献
9.
Bridget A. Bagert 《Current neurology and neuroscience reports》2009,9(5):405-410
Recent seroepidemiologic and pathologic evidence suggests that prior infection with Epstein-Barr virus (EBV) may be necessary
for the development of multiple sclerosis (MS). EBV infects more than 90% of all humans, most of whom remain healthy. In contrast,
99% of MS patients have evidence of prior infection with EBV. EBV infects resting B lymphocytes, immortalizing them into long-lived
memory B cells that survive largely undetected by the immune system in the peripheral circulation. MS patients show elevated
titers to EBV years before developing any neurologic symptoms. Postmortem pathologic analysis of brains of patients with MS
has revealed diffuse EBV-associated B-cell dysregulation in all forms of MS. Theories of pathogenesis of EBV in MS include
antigenic mimicry, immortalization of B-cell clones, and cytotoxic T-cell dysfunction against virally infected B cells. This
article reviews the existing evidence of the relationship between EBV and MS and considers the therapeutic implication of
this evidence. 相似文献
10.